Coulter G, Young D A, Dalziel R E, Shimmin A J
Melbourne Orthopaedic Group, 33 The Avenue Windsor, Melbourne 3181, Australia.
J Bone Joint Surg Br. 2012 Mar;94(3):315-21. doi: 10.1302/0301-620X.94B3.28185.
We report the findings of an independent review of 230 consecutive Birmingham hip resurfacings (BHRs) in 213 patients (230 hips) at a mean follow-up of 10.4 years (9.6 to 11.7). A total of 11 hips underwent revision; six patients (six hips) died from unrelated causes; and 13 patients (16 hips) were lost to follow-up. The survival rate for the whole cohort was 94.5% (95% confidence interval (CI) 90.1 to 96.9). The survival rate in women was 89.1% (95% CI 79.2 to 94.4) and in men was 97.5% (95% CI 92.4 to 99.2). Women were 1.4 times more likely to suffer failure than men. For each millimetre increase in component size there was a 19% lower chance of a failure. The mean Oxford hip score was 45.0 (median 47.0, 28 to 48); mean University of California, Los Angeles activity score was 7.4 (median 8.0, 3 to 9); mean patient satisfaction score was 1.4 (median 1.0, 0 to 9). A total of eight hips had lysis in the femoral neck and two hips had acetabular lysis. One hip had progressive radiological changes around the peg of the femoral component. There was no evidence of progressive neck narrowing between five and ten years. Our results confirm that BHR provides good functional outcome and durability for men, at a mean follow-up of ten years. We are now reluctant to undertake hip resurfacing in women with this implant.
我们报告了一项对213例患者(230髋)连续进行的230例伯明翰髋关节表面置换术(BHR)的独立评估结果,平均随访时间为10.4年(9.6至11.7年)。共有11髋进行了翻修;6例患者(6髋)因无关原因死亡;13例患者(16髋)失访。整个队列的生存率为94.5%(95%置信区间(CI)90.1至96.9)。女性的生存率为89.1%(95%CI 79.2至94.4),男性为97.5%(95%CI 92.4至99.2)。女性发生失败的可能性是男性的1.4倍。假体尺寸每增加1毫米,失败的几率降低19%。牛津髋关节平均评分为45.0(中位数47.0,范围28至48);加利福尼亚大学洛杉矶分校活动平均评分为7.4(中位数8.0,范围3至9);患者平均满意度评分为1.4(中位数1.0,范围0至9)。共有8髋出现股骨颈骨溶解,2髋出现髋臼骨溶解。1髋在股骨假体柄周围有进行性放射学改变。在5至10年之间没有进行性颈缩窄的证据。我们的结果证实,在平均10年的随访中,BHR为男性提供了良好的功能结果和耐用性。我们现在不愿意对使用这种假体的女性进行髋关节表面置换术。